ES2116642T3 - Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol. - Google Patents

Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol.

Info

Publication number
ES2116642T3
ES2116642T3 ES95105766T ES95105766T ES2116642T3 ES 2116642 T3 ES2116642 T3 ES 2116642T3 ES 95105766 T ES95105766 T ES 95105766T ES 95105766 T ES95105766 T ES 95105766T ES 2116642 T3 ES2116642 T3 ES 2116642T3
Authority
ES
Spain
Prior art keywords
xantohumol
pharmaceutical composition
treat osteoporosis
osteoporosis containing
osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95105766T
Other languages
English (en)
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Osamu Komiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOECHST MARION ROUSSEL Ltd
Sanofi Aventis KK
Original Assignee
HOECHST MARION ROUSSEL Ltd
Nippon Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOECHST MARION ROUSSEL Ltd, Nippon Hoechst Marion Roussel Ltd filed Critical HOECHST MARION ROUSSEL Ltd
Application granted granted Critical
Publication of ES2116642T3 publication Critical patent/ES2116642T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN AGENTE TERAPEUTICO PARA OSTEOPOROSIS QUE COMPRENDE COMO UN INGREDIENTE ACTIVO XANTOHUMOL. EL XANTOHUMOL OBTENIDO DE EXTRACTOS DE LUPULO TIENE UNA ACTIVIDAD PARA INHIBIR LA RESORCION OSEA Y ES UTIL COMO UN AGENTE TERAPEUTICO PARA OSTEOPOROSIS.
ES95105766T 1994-04-21 1995-04-18 Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol. Expired - Lifetime ES2116642T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6082852A JPH07285856A (ja) 1994-04-21 1994-04-21 骨粗鬆症治療剤

Publications (1)

Publication Number Publication Date
ES2116642T3 true ES2116642T3 (es) 1998-07-16

Family

ID=13785904

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95105766T Expired - Lifetime ES2116642T3 (es) 1994-04-21 1995-04-18 Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol.

Country Status (14)

Country Link
US (1) US5679716A (es)
EP (1) EP0679393B1 (es)
JP (1) JPH07285856A (es)
KR (1) KR100350564B1 (es)
AT (1) ATE162073T1 (es)
AU (1) AU695696B2 (es)
CA (1) CA2147419A1 (es)
DE (1) DE69501419T2 (es)
DK (1) DK0679393T3 (es)
ES (1) ES2116642T3 (es)
FI (1) FI951856A7 (es)
HU (1) HUT71603A (es)
NO (1) NO951498L (es)
TW (1) TW284687B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung
KR20060095786A (ko) * 2000-01-27 2006-09-01 다카라 바이오 가부시키가이샤 치료제
EP1277473A4 (en) * 2000-04-10 2005-12-28 Takara Bio Inc REMEDIES
US6352726B1 (en) * 2001-01-09 2002-03-05 S. S. Steiner, Inc. Method of killing protozoa
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
US20060233902A1 (en) * 2002-02-14 2006-10-19 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism
AU2002257721A1 (en) * 2002-04-24 2003-11-10 Unilever Plc Use of hop components in foods
DE10240065B4 (de) * 2002-08-30 2004-10-28 Hallertauer Hopfenveredlungsgesellschaft M.B.H. Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt
DE50302729D1 (de) * 2002-12-18 2006-05-11 Doehler Gmbh Xanthohumol-haltiges Getränk
DE602004016486D1 (de) * 2003-04-08 2008-10-23 Kirin Brewery Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
EP1909584A4 (en) * 2005-07-29 2010-07-07 Bioactives Inc PRENYLFLAVONOID FORMULATIONS
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
KR101323150B1 (ko) * 2011-04-25 2013-10-30 충남대학교산학협력단 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
BR112015001595A2 (pt) * 2012-07-26 2018-06-19 Ta-Xan Ag composição farmacêutica, uso de um extrato torrado, e, método para intensificar um ou mais efeito (s) terapêutico (s) de xantohumol e para a produção de uma composição farmacêutica
JP6009498B2 (ja) * 2014-06-24 2016-10-19 国立大学法人京都大学 アルツハイマー病予防薬
US20180193287A1 (en) 2015-07-02 2018-07-12 John I. Haas, Inc. Hops-based substance and use of the substance
CN105477686B (zh) * 2015-11-30 2019-02-15 长春工业大学 一种包覆黄腐酚的纳米纤维膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794744A (en) * 1972-05-10 1974-02-26 White Tomkins Ltd Purification of hop extracts
US4065574A (en) * 1975-08-29 1977-12-27 The Upjohn Company New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds

Also Published As

Publication number Publication date
US5679716A (en) 1997-10-21
KR950031060A (ko) 1995-12-18
AU1653595A (en) 1995-10-19
EP0679393A3 (en) 1995-11-15
ATE162073T1 (de) 1998-01-15
FI951856L (fi) 1995-10-22
JPH07285856A (ja) 1995-10-31
KR100350564B1 (ko) 2002-12-16
DE69501419D1 (de) 1998-02-19
DK0679393T3 (da) 1998-09-14
HU9501121D0 (en) 1995-06-28
HUT71603A (en) 1996-01-29
FI951856A7 (fi) 1995-10-22
FI951856A0 (fi) 1995-04-19
NO951498L (no) 1995-10-23
DE69501419T2 (de) 1998-06-25
EP0679393A2 (en) 1995-11-02
TW284687B (es) 1996-09-01
EP0679393B1 (en) 1998-01-14
AU695696B2 (en) 1998-08-20
NO951498D0 (no) 1995-04-20
CA2147419A1 (en) 1995-10-22

Similar Documents

Publication Publication Date Title
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
MXPA02005173A (es) Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea.
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
ES2161886T3 (es) Composiciones en barra de gel que comprenden gelificantes opticamente enriquecidos.
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
ES2242218T3 (es) Composiciones farmaceuticas que contienen aceite de semilla del arbol candil.
DE69713485D1 (de) Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
UA90077C2 (uk) Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
ES2136139T3 (es) Componente farmaceutico de accion ralentizada que contiene acido bilico como componente activo.
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES2171669T3 (es) Composicion farmaceutica que contiene hidrocloruro de tiagabina y su procedimiento de preparacion.
AR005969A1 (es) Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
ES2126265T3 (es) Tableta de accion retardada con un cierto contenido de diclorofenaco de sodio.
AR002647A1 (es) Composiciones insecicidas que incluyen compuestos de 1-fenil o 1-piridin-2-il-pirazol como agente activo y procedimiento para combatir insectos con aplicación de dichas composiciones
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
ES2191426T3 (es) Composiciones estables que comprenden levosimendano y acido alginico.
PT1063969E (pt) Formulacao topica do tipo oleo-em-agua como um transportador para proporcionar um reduzido efeito de irritacao
ES2121109T3 (es) Composicion de champu.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ES2148268T3 (es) Composicion farmaceutica para prevenir o tratar fracturas de huesos.
ES2075934T3 (es) Metodo y composicion de iontoforesis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 679393

Country of ref document: ES